x

Cerca una sperimentazione clinica

* (*) campo obbligatorio

22 Risultato/i

Ordinato per

Sperimentazione in fase di reclutamento = Sperimentazione in fase di reclutamento
; Sperimentazione in corso = Sperimentazione in corso
; Finanziato da un ente associato a IRDiRC =

Sperimentazioni cliniche nazionali

FRANCIA

ILE-DE-FRANCE
PARIS

MAINRISTAN: MAINtenance of Remission Using RITuximab in Systemic ANCA-associated Vasculitis (Phase III)
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

FRANCIA

ILE-DE-FRANCE
PARIS

IMPROVE: International mycophenolate mofetil protocol to reduce out breaks of vasculitis (Phase III)
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

FRANCIA

ILE-DE-FRANCE
PARIS

CORTAGE : Treatment of necrotizing vasculitis in elderly (65 years old and over) (Phase IV)
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

FRANCIA

ILE-DE-FRANCE
PARIS

Sperimentazione in fase di reclutamento
Sperimentazione in corso
CHUSPAN2 : Evaluation of a New Treatment Strategy for Patients With Microscopic Polyangiitis, Polyarteritis Nodosa or Churg Strauss Syndrome Without Poor Prognosis Factors (Phase III)
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

PAESI BASSI

Groningen
GRONINGEN

PAESI BASSI

Groningen
GRONINGEN

Rituximab for the Treatment of Wegener's Granulomatosis and Microscopic Polyangiitis
UMCG - Universitair Medisch Centrum Groningen
Afdeling Reumatologie & Klinische Immunologie

FRANCIA

ILE-DE-FRANCE
PARIS

RATTRAP : Infliximab versus rituximab in systemic necrosing vascularizes with positive ANCA after relapse or resistant immunosuppressant therapies (Phase III) - Terminated -
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

FRANCIA

ILE-DE-FRANCE
PARIS

Sperimentazione in corso
PEXIVAS: Plasma Exchange and Glucocorticoid Dosing in the Treatment of Anti-neutrophil Cytoplasm Antibody Associated Vasculitis. An International Randomised Controlled Trial (phase III) - FR
CHU Paris Centre - Hôpital Cochin, Site Cochin
Unité fonctionnelle de Médecine interne et centre de référence maladies rares

REGNO UNITO; GRAN BRETAGNA

Cambridgeshire
CAMBRIDGE

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

ABAVAS: Abatacept in ANCA associated vasculitis (phase II-III)
Hammersmith Hospital
Renal Section, Division of Medicine

REGNO UNITO; GRAN BRETAGNA

Lothian
EDINBURGH

Sperimentazione in fase di reclutamento
Sperimentazione in corso
The Vascular Effects of Endothelin Receptor Antagonism in Systemic Vasculitis
School of Informatics, The University of Edinburgh
University of Edinburgh

REGNO UNITO; GRAN BRETAGNA

Cambridgeshire
CAMBRIDGE

REGNO UNITO; GRAN BRETAGNA

Greater London
LONDON

Sperimentazioni cliniche internazionali